Deletion in mice of X-linked, Brugada syndrome- and atrial fibrillation-associated Kcne5 augments ventricular K currents and predisposes to ventricular arrhythmia.

Jens-Peter David, Ulrike Lisewski, Shawn M Crump, Thomas A Jepps, Elke Bocksteins, Nicola Wilck, Janine Lossie, Torsten K Roepke, Nicole Schmitt, Geoffrey W Abbott
Author Information
  1. Jens-Peter David: Danish National Research Foundation Centre for Cardiac Arrhythmia, University of Copenhagen, Copenhagen, Denmark.
  2. Ulrike Lisewski: Medical Clinic and Polyclinic for Cardiology and Angiology, Charité Medical University of Berlin, Berlin, Germany.
  3. Shawn M Crump: Bioelectricity Laboratory, Department of Physiology and Biophysics, University of California, Irvine, Irvine, California, USA; and.
  4. Thomas A Jepps: Danish National Research Foundation Centre for Cardiac Arrhythmia, University of Copenhagen, Copenhagen, Denmark.
  5. Elke Bocksteins: Laboratory for Molecular Biophysics, Physiology, and Pharmacology, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  6. Nicola Wilck: Medical Clinic and Polyclinic for Cardiology and Angiology, Charité Medical University of Berlin, Berlin, Germany.
  7. Janine Lossie: Medical Clinic and Polyclinic for Cardiology and Angiology, Charité Medical University of Berlin, Berlin, Germany.
  8. Torsten K Roepke: Medical Clinic and Polyclinic for Cardiology and Angiology, Charité Medical University of Berlin, Berlin, Germany.
  9. Nicole Schmitt: Danish National Research Foundation Centre for Cardiac Arrhythmia, University of Copenhagen, Copenhagen, Denmark.
  10. Geoffrey W Abbott: Bioelectricity Laboratory, Department of Physiology and Biophysics, University of California, Irvine, Irvine, California, USA; and.

Abstract

KCNE5 is an X-linked gene encoding KCNE5, an ancillary subunit to voltage-gated potassium (K) channels. Human KCNE5 mutations are associated with atrial fibrillation (AF)- and Brugada syndrome (BrS)-induced cardiac arrhythmias that can arise from increased potassium current in cardiomyocytes. Seeking to establish underlying molecular mechanisms, we created and studied Kcne5 knockout ( Kcne5) mice. Intracardiac ECG revealed that Kcne5 deletion caused ventricular premature beats, increased susceptibility to induction of polymorphic ventricular tachycardia (60 vs. 24% in Kcne5 mice), and 10% shorter ventricular refractory period. Kcne5 deletion increased mean ventricular myocyte K current density in the apex and also in the subpopulation of septal myocytes that lack fast transient outward current ( I). The current increases arose from an apex-specific increase in slow transient outward current-1 ( I) (conducted by K1.5) and I (conducted by K4) and an increase in I (conducted by K2.1) in both apex and septum. Kcne5 protein localized to the intercalated discs in ventricular myocytes, where K2.1 was also detected in both Kcne5 and Kcne5 mice. In HL-1 cardiac cells and human embryonic kidney cells, KCNE5 and K2.1 colocalized at the cell surface, but predominantly in intracellular vesicles, suggesting that Kcne5 deletion increases I by reducing K2.1 intracellular sequestration. The human AF-associated mutation KCNE5-L65F negative shifted the voltage dependence of K2.1-KCNE5 channels, increasing their maximum current density >2-fold, whereas BrS-associated KCNE5 mutations produced more subtle negative shifts in K2.1 voltage dependence. The findings represent the first reported native role for Kcne5 and the first demonstrated Kcne regulation of K2.1 in mouse heart. Increased K current is a manifestation of KCNE5 disruption that is most likely common to both mouse and human hearts, providing a plausible mechanistic basis for human KCNE5-linked AF and BrS.-David, J.-P., Lisewski, U., Crump, S. M., Jepps, T. A., Bocksteins, E., Wilck, N., Lossie, J., Roepke, T. K., Schmitt, N., Abbott, G. W. Deletion in mice of X-linked, Brugada syndrome- and atrial fibrillation-associated Kcne5 augments ventricular K currents and predisposes to ventricular arrhythmia.

Keywords

References

  1. Cardiovasc Res. 2005 Aug 15;67(3):529-38 [PMID: 16039274]
  2. Front Genet. 2014 Jan 24;5:3 [PMID: 24478792]
  3. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2926-31 [PMID: 9501192]
  4. Am J Physiol Heart Circ Physiol. 2003 Feb;284(2):H491-500 [PMID: 12529256]
  5. Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H229-37 [PMID: 17965280]
  6. FASEB J. 2016 Jul;30(7):2476-89 [PMID: 26985008]
  7. J Gen Physiol. 1999 May;113(5):661-78 [PMID: 10228181]
  8. Sci Rep. 2018 May 29;8(1):8258 [PMID: 29844497]
  9. Heart Rhythm. 2014 Feb;11(2):246-51 [PMID: 24144883]
  10. J Vasc Res. 2016;53(3-4):138-148 [PMID: 27710966]
  11. Methods. 2001 Dec;25(4):402-8 [PMID: 11846609]
  12. FASEB J. 2008 Oct;22(10):3648-60 [PMID: 18603586]
  13. Traffic. 2013 Apr;14(4):399-411 [PMID: 23324056]
  14. Circ Cardiovasc Genet. 2014 Feb;7(1):33-42 [PMID: 24403551]
  15. Genomics. 1999 Sep 15;60(3):251-7 [PMID: 10493825]
  16. Nat Med. 2009 Oct;15(10):1186-94 [PMID: 19767733]
  17. Circ Arrhythm Electrophysiol. 2011 Jun;4(3):352-61 [PMID: 21493962]
  18. Sci Rep. 2015 Aug 05;5:12813 [PMID: 26242757]
  19. Front Physiol. 2017 Feb 08;8:66 [PMID: 28228734]
  20. J Physiol. 2007 Jul 15;582(Pt 2):675-93 [PMID: 17478540]
  21. Sci Rep. 2016 Mar 17;6:23118 [PMID: 26984260]
  22. Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 [PMID: 12184808]
  23. FASEB J. 2017 Jun;31(6):2674-2685 [PMID: 28280005]
  24. Neuropharmacology. 2004 Nov;47(6):787-821 [PMID: 15527815]
  25. J Med Genet. 1998 Apr;35(4):273-8 [PMID: 9598718]
  26. Am J Cardiol. 2005 Aug 1;96(3):405-7 [PMID: 16054468]
  27. Circ Res. 1998 Jul 13;83(1):95-102 [PMID: 9670922]
  28. Physiol Rev. 2014 Apr;94(2):609-53 [PMID: 24692356]
  29. Nature. 1996 Nov 7;384(6604):80-3 [PMID: 8900283]
  30. Cardiovasc Res. 2006 Sep 1;71(4):695-703 [PMID: 16876774]
  31. Circ Res. 1997 Jun;80(6):772-81 [PMID: 9168779]
  32. Clin Genet. 1994 Jun;45(6):314-7 [PMID: 7923864]
  33. FASEB J. 2014 Feb;28(2):935-45 [PMID: 24225147]
  34. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2979-84 [PMID: 9501201]
  35. Circulation. 1998 Oct 6;98(14):1383-93 [PMID: 9760292]
  36. Neuron. 1996 Dec;17(6):1251-64 [PMID: 8982171]
  37. Gene. 2015 Sep 15;569(2):162-72 [PMID: 26123744]
  38. Gene. 2016 Nov 30;593(2):249-60 [PMID: 27484720]
  39. J Mol Cell Cardiol. 2005 Feb;38(2):277-87 [PMID: 15698834]
  40. Pflugers Arch. 2009 Nov;459(1):11-23 [PMID: 19768467]
  41. Am J Physiol Regul Integr Comp Physiol. 2002 Mar;282(3):R639-48 [PMID: 11832382]
  42. Heart Rhythm. 2008 Mar;5(3):427-35 [PMID: 18313602]
  43. Gene. 2016 Jan 15;576(1 Pt 1):1-13 [PMID: 26410412]
  44. Nature. 1996 Nov 7;384(6604):78-80 [PMID: 8900282]
  45. FASEB J. 2016 Jan;30(1):360-9 [PMID: 26399785]
  46. J Physiol. 2000 Dec 1;529 Pt 2:345-58 [PMID: 11101645]
  47. J Membr Biol. 2009 Mar;228(1):1-14 [PMID: 19219384]

Grants

  1. R01 HL079275/NHLBI NIH HHS

MeSH Term

Animals
Atrial Fibrillation
Brugada Syndrome
Cells, Cultured
Female
Genes, X-Linked
HEK293 Cells
Humans
Ion Channel Gating
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Myocytes, Cardiac
Potassium
Potassium Channels, Voltage-Gated
Sequence Deletion
Tachycardia, Ventricular

Chemicals

KCNE5 protein, human
Potassium Channels, Voltage-Gated
Potassium

Word Cloud

Created with Highcharts 10.0.0Kcne5ventricularK2KCNE5Kcurrent1micehumanX-linkedpotassiumatrialBrugadaincreaseddeletionconductedchannelsmutationsAFBrScardiacdensityapexalsomyocytestransientoutwardincreasesincreasecellsintracellularnegativevoltagedependencefirstmouseJTNDeletionsyndrome-fibrillation-associatedaugmentscurrentspredisposesarrhythmiageneencodingancillarysubunitvoltage-gatedHumanassociatedfibrillation-syndrome-inducedarrhythmiascanarisecardiomyocytesSeekingestablishunderlyingmolecularmechanismscreatedstudiedknockoutIntracardiacECGrevealedcausedprematurebeatssusceptibilityinductionpolymorphictachycardia60vs24%10%shorterrefractoryperiodmeanmyocytesubpopulationseptallackfastaroseapex-specificslowcurrent-1K15K4septumproteinlocalizedintercalateddiscsdetectedHL-1embryonickidneycolocalizedcellsurfacepredominantlyvesiclessuggestingreducingsequestrationAF-associatedmutationKCNE5-L65Fshifted1-KCNE5increasingmaximum>2-foldwhereasBrS-associatedproducedsubtleshiftsfindingsrepresentreportednativeroledemonstratedKcneregulationheartIncreasedmanifestationdisruptionlikelycommonheartsprovidingplausiblemechanisticbasisKCNE5-linked-David-PLisewskiUCrumpSMJeppsABocksteinsEWilckLossieRoepkeSchmittAbbottGWMiRP4channel

Similar Articles

Cited By